Similar overall survivals of wedge resection and segmentectomy in stage IA1 non-small cell lung cancer: a population-based study using propensity score matching and coarsened exact matching

IA1期非小细胞肺癌楔形切除术和肺段切除术的总生存率相似:一项基于人群的倾向评分匹配和粗化精确匹配研究

阅读:1

Abstract

BACKGROUND: Controversy continues over the application of wedge resection and segmentectomy for the early stage of non-small cell lung cancer (NSCLC) without affecting long-term survival. This study aimed to investigate the acceptability of wedge resection as an alternative to segmentectomy in patients with T1aN0M0 NSCLC with data from the Surveillance, Epidemiology, and End Results (SEER) database. METHODS: A total of 742 patients with pT1aN0M0 NSCLC from the SEER database were finally involved in this study, including 130 patients in the segmentectomy group and 612 patients in the wedge resection group. Three matching methods, including propensity score matching (PSM), coarsened exact matching (CEM), and inverse probability of treatment weighting using the propensity score (IPTW) were introduced to control and minimize the potential bias. Prognostic analysis was conducted using the Kaplan-Meier method and Cox regression after matching the two groups (P<0.02). RESULTS: After matching, wedge resection and segmentectomy pairs were well matched without significant differences in all clinical and tumor factors. The prognostic analysis of overall survival (OS) showed no significant difference between wedge resection and segmentectomy in PSM analysis (log-rank test, P=0.08), IPTW analysis (log-rank test, P=0.09), and CEM analysis (log-rank test, P=0.03), respectively. The multivariant Cox analysis revealed that age (P<0.001), sex (P<0.001), histology (P<0.001) and grade (P=0.004) were significant independent prognostic factors for OS. CONCLUSIONS: Wedge resection could be an alternative procedure for patients with pT1aN0M0 NSCLC without affecting survival.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。